ArticleCommunications biology2026
ZIKV envelope protein is a strong blocker of early directional differentiation in the neural lineage.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zika virus (ZIKV) infection is an international concern of public health emergency and has been associated with severe neurodevelopmental abnormalities. ZIKV-encoded envelope protein was virulent to neural cells, but its role in the neurodifferentiation process is not well known. Thus, we used mouse embryonic stem cells (mESCs) to mimic early neural differentiation in vitro and comprehensively studied the role of ZIKV envelope protein in the early directional differentiation of the neural lineage. We found that the ZIKV envelope protein does not affect the pluripotency of mESCs, but is a strong blocker of early neural differentiation. In both monolayer and suspension culture neural differentiation models, abnormalities arise from neural lineage commitment to early neuronal differentiation. During differentiation, envelope protein downregulated a large number of neurodevelopmentally relevant genes, therefore inhibiting multiple key biological processes, including neuroactive ligand-receptor interactions, neuron, synaptic processes, and dendritic spine development. ZIKV envelope protein disrupts early directed differentiation within neural lineages, providing key evidence for ZIKV-mediated neurodevelopmental abnormalities such as fetal microcephaly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.